Valencia Nutrition Ltd.
Valencia Nutrition
₹ 0.00
0.00 (0.00)%
NSE
BSE
FMCG
Small-cap - With a market cap of ₹1.13 Cr.
| EX-Date | Purpose |
|---|---|
| 09 07 2021 | Audited Results & Inter alia, to transact the following business: 1. To consider, approve and take on records the Audited Financial Results for the Quarter and year ended as on 31st March, 2021. 2. To consider and approve appointment of the Secretarial Auditor of the Company for the year 2020-21. 3. Any other matter with the permission of the Chair. |
| 12 11 2021 | Half Yearly Results |
| 30 05 2022 | Audited Results (Revised) |
| 31 05 2022 | Audited Results |
| 14 11 2022 | Increase in Authorised Capital & Half Yearly Results Inter alia, to consider and approve:- 1. To appoint an Internal Auditor of the Company. 2. To increase the authorized share capital of the Company. 3. To approve the fundraising by way of a loan to be availed from the Director of the Company, which shall be converted into equity shares at a later date. 4. To consider and approve notice of the Extra-Ordinary General Meeting (EGM) to seek approval for the above-mentioned items as recommended by the Board. 5. To appoint the Scrutiniser. 6. Any other matter with the permission of the Chair. |
| 29 05 2023 | Audited Results |
| 10 11 2023 | Half Yearly Results |
| 20 11 2023 | Inter alia, to consider and approve the proposal for fund raising by the issue of permissible securities including a rights issue, preferential issue or through any other permissible mode or a combination thereof, subject to such regulatory/ statutory approvals as may be required. |
| 12 12 2023 | Inter alia, to consider and approve the following business: 1. Reclassification of Ms. Deepthi Anand from Promoter/Promoter Group to Public Category? pursuant to Regulation 31A of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. The Management has proposed to revise the size of the raising of funds earlier decided in the Board Meeting held on November 20, 2022, through issuance and allotment of equity shares on right issue basis from an aggregate amount of up to Rs. 14,00,00,000 (Rupees Fourteen Crores Only) to not more than Rs. 22,00,00,000 (Rupees Twenty-Two Crores Only). 3. Any other matter with the permission of the Chair. |
| 30 12 2023 | Inter alia, to consider and approve the following: 1. Draft Letter of Offer for the proposed rights issue for an aggregate amount up to Rs. 22,00,00,000 (Rupees Twenty Two Crores Only) in accordance with the applicable laws including the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the Companies Act, 2013 and rules made there under, as amended from time to time and 2. Any other matter with the permission of the Chair. |
| 13 11 2024 | Half Yearly Results |
| 13 02 2025 | Inter alia, to transact the following businesses: 1. To approve the proposal for fundraising by the issue of permissible securities including a preferential issue or through any other permissible mode or a combination thereof, subject to such regulatory, statutory approvals as may be required. 2. Any other matter with the permission of the Chair. |
| 28 05 2025 | Audited Results |
| 13 11 2025 | Half Yearly Results |
